Immediate Impact

4 from Science/Nature 83 standout
Sub-graph 1 of 21

Citing Papers

Ulcerative colitis
2023 Standout
Newer Biologic and Small-Molecule Therapies for Inflammatory Bowel Disease
2021 Standout
6 intermediate papers

Works of Mark I. Hamilton being referenced

A pilot study of treatment of active ulcerative colitis with natalizumab, a humanized monoclonal antibody to alpha‐4 integrin
2002
A randomized placebo-controlled trial of a humanized monoclonal antibody to α4 integrin in active crohn's disease
2001

Author Peers

Author Last Decade Papers Cites
Mark I. Hamilton 147 366 254 165 13 583
Torao Tanaka 193 423 170 283 12 657
Eva Ellinghaus 125 160 109 197 17 694
Paul Hellstern 103 251 236 165 16 580
WJ Tremaine 178 371 350 100 16 613
Rosalind Sim 241 244 181 89 9 615
Aušrinė Barakauskienė 192 330 305 101 14 542
Parker J. Staples 87 74 138 297 14 664
H Both 167 287 274 164 9 657
L Salde 167 340 330 69 13 537
Keith Leiper 214 307 224 100 23 595

All Works

Loading papers...

Rankless by CCL
2026